CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from revolving credit facilities	$ 0	$ 412.0
Payments on zero-coupon subordinated notes	(16.8)	(21.3)
Payments on long-term debt	0	(350.0)
Noncontrolling interest distributions	(0.9)	(0.6)
Deferred payments on acquisitions	(5.2)	(5.6)
Repayments of Long-term Capital Lease Obligations	(0.6)	0
Excess tax benefits from stock based compensation	5.5	8.7
Net proceeds from issuance of stock to employees	106.2	148.6
Purchase of common stock	(229.9)	(765.5)
Payments on revolving credit facilities	0	(40.0)
Net cash provided by (used for) financing activities	(141.8)	(613.7)
Payments of Debt Issuance Costs	0.1	0
CASH FLOWS FROM OPERATING ACTIVITIES:
Net earnings	392.7	448.7
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	182.0	170.3
Stock compensation	35.1	28.9
Loss on sale of assets	(16.0)	(4.3)
Accrued interest on zero-coupon subordinated notes	1.5	1.8
Cumulative earnings in excess of distributions from equity method investments	(3.3)	(1.7)
Deferred income taxes	(3.5)	28.3
Change in assets and liabilities (net of effects of acquisitions):
Increase in accounts receivable (net)	(59.7)	(95.5)
Increase in inventories	(1.3)	(5.6)
Decrease in prepaid expenses and other	1.7	(5.3)
Decrease in accounts payable	(16.2)	25.2
Increase (decrease) in accrued expenses and other	12.3	(20.8)
Net cash provided by operating activities	525.3	570.0
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(157.2)	(142.6)
Proceeds from sale of assets	0.9	0.6
Payments for (Proceeds from) Investments	31.7	7.5
Investments in equity affiliates	(12.9)	(3.3)
Acquisition of businesses, net of cash acquired	(65.3)	(109.0)
Net cash used for investing activities	(202.8)	(246.8)
Effect of exchange rate changes on cash and cash equivalents	(9.0)	(2.2)
Net increase (decrease) in cash and cash equivalents	171.7	(292.7)
Cash and cash equivalents at beginning of period	404.0	466.8
Cash and cash equivalents at end of period	$ 575.7	$ 174.1